GW & Wade’s VanEck Biotech ETF BBH Stock Holding History

GW & Wade’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$214K	Hold	1,295	–	–	0.01%	384
2023 Q3	$202K	Hold	1,295	–	–	0.01%	385
2023 Q2	$202K	Hold	1,295	–	–	0.01%	368
2023 Q1	$210K	Hold	1,295	–	–	0.01%	355
2022 Q4	$207K	Buy	+1,295	New	+$205K	0.01%	362
2022 Q2	–	Sell	-1,295	Closed	-$210K	–	386
2022 Q1	$210K	Hold	1,295	–	–	0.01%	373
2021 Q4	$245K	Hold	1,295	–	–	0.01%	358
2021 Q3	$262K	Hold	1,295	–	–	0.01%	327
2021 Q2	$261K	Hold	1,295	–	–	0.01%	333
2021 Q1	$227K	Hold	1,295	–	–	0.01%	330
2020 Q4	$220K	Hold	1,295	–	–	0.01%	290
2020 Q3	$210K	Buy	+1,295	New	+$211K	0.02%	227

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIG

Consolidated Investment Group Englewood, Colorado $1.15B AUM 55.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

GW & Wade's BBH Position: Q4 2023 in Review

GW & Wade held its VanEck Biotech ETF (BBH) position steady in Q4 2023 at 1,295 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #384.

GW & Wade first reported a position in BBH in Q3 2020 and has held it in 12 quarters since. The position peaked at $262K in Q3 2021. 116 funds tracked by Wall St. Rank hold BBH as of Q4 2023.

GW & Wade held 1,295 shares of VanEck Biotech ETF worth $214K as of Q4 2023.
GW & Wade left its VanEck Biotech ETF share count unchanged in Q4 2023.
VanEck Biotech ETF made up 0.01% of GW & Wade's portfolio in Q4 2023, its #384 holding.
GW & Wade first reported a position in VanEck Biotech ETF in Q3 2020 and has held it in 12 quarters since.
GW & Wade's VanEck Biotech ETF position peaked at $262K in Q3 2021.
116 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.